Sign Up to like & get
recommendations!
2
Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2021006325
Abstract: Key Points Genetically matched MDS-RS and normal patient-specific iPSC-HSPCs are used to derive a mutant SF3B1 splicing signature. Integrated transcriptomics and chromatin accessibility nominate TEAD as a putative novel transcriptional regulator of SF3B1K700E cells.
read more here.
Keywords:
patient specific;
ipscs define;
mds ipscs;
hspcs ... See more keywords